Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How safe is Stem Cell Therapy for Joint Pain?

Stem cell therapy for joint pain has a favorable safety profile in clinical research.

Free Consultation
Joints location on a neutral human figure

In the most studied application, knee osteoarthritis, a 2024 meta-analysis of 25 randomized controlled trials with more than 1,000 participants found no difference in serious adverse events between patients who received mesenchymal stromal cells (MSCs) and those who received control treatments. The most common side effects are temporary and local: pain, swelling, stiffness or bruising at the injection site for about three to seven days. Rare risks include joint infection, bleeding and allergic reactions, which are minimized by sterile technique, ultrasound guidance, careful screening and a documented cell product. At Stem Cell Mexico, joint treatments use allogeneic MSCs derived from umbilical cord tissue, often combined with platelet-rich plasma (PRP), injected by specialists under ultrasound guidance. Not every patient is a candidate, and treatment is declined when the risks outweigh the expected benefit.

This guide explains what the evidence shows, what to expect after treatment, which factors increase risk and how risks are reduced.

What the evidence shows

Randomized trials in knee osteoarthritis

The meta-analysis published in the Journal of Orthopaedic Translation (Tabet and colleagues, 2024) pooled 25 randomized trials of MSC injections for knee osteoarthritis. Serious adverse events were not more frequent with MSCs than with placebo or hyaluronic acid. The same analysis found improvements in pain and function.

Other joints

Evidence for the hip, shoulder, ankle and smaller joints comes from smaller studies, but the safety pattern is similar: mostly temporary local reactions, with serious complications uncommon.

Context from guidelines and regulators

The UK's National Institute for Health and Care Excellence (NICE) osteoarthritis guideline (NG226) focuses on exercise, weight management, education and, when needed, medications or joint replacement, and does not include cell therapy among routine recommendations, reflecting the need for more large trials rather than evidence of harm. The U.S. Food and Drug Administration (FDA) has warned consumers that no stem cell or exosome products are approved in the United States for orthopedic conditions and that some products are marketed without adequate oversight. This is why the quality and documentation of the cell product matter as much as the procedure itself.

Common side effects

  • Post-injection pain and swelling: usually peaks in the first two to three days and settles within about a week. It reflects the injection volume and a local inflammatory response, not a failed treatment.
  • Stiffness: common for several days, especially in the knee and shoulder.
  • Bruising at the injection site.
  • Temporary limp or reduced range of motion while swelling settles.
  • Mild fatigue after sedation, if used.

These effects are managed with relative rest, paracetamol if needed and, after the first two days, short applications of ice or heat as instructed.

Rare but important risks

Joint infection (septic arthritis)

Any injection into a joint carries a small risk of infection. It is rare with strict sterile technique, but it is serious if it occurs. Warning signs include increasing pain, heat, redness and swelling after the first few days, often with fever.

Bleeding

Small bleeds into or around the joint can occur, especially in people taking blood thinners. These medications are reviewed in advance and never stopped without medical guidance.

Allergic reactions

Rare reactions to components used in cell preparation, local anesthetics or antiseptics.

Nerve or vessel irritation

Reduced by ultrasound guidance, which allows the specialist to see structures in real time.

Flare of inflammation

Some patients experience a stronger inflammatory reaction for several days, which usually resolves with rest and simple measures.

Joint-by-joint safety notes

  • Knee: the most studied joint. Post-injection swelling is common because the knee holds more fluid; temporary difficulty bending the knee fully can occur.
  • Hip: a deep joint that requires precise image guidance. Groin or thigh discomfort for several days is common.
  • Shoulder: injections may include the joint, rotator cuff and bursa. Night pain and stiffness can increase briefly.
  • Ankle and foot: swelling may be more noticeable when standing, so elevating the leg helps.
  • Elbow, wrist and hand: smaller volumes are used, and soreness is usually short-lived, though small joints can feel tight for a few days.

Factors that increase risk

  • Active infection anywhere in the body or skin problems over the injection site.
  • Uncontrolled diabetes or immune suppression, which raise infection risk.
  • Blood thinners or bleeding disorders.
  • A recent corticosteroid injection in the same joint, which may affect timing.
  • Severe joint deformity or instability, where injections are less likely to help.
  • Joint replacement in the same joint (prosthetic joints are not injected with cells).

How we reduce risk

  • Medical review before acceptance: imaging, symptoms, medications and history are reviewed by a specialist. We decline treatment when we believe it is unlikely to help or when risks outweigh benefits.
  • Pre-treatment testing: complete blood count, metabolic panel, urinalysis and tumor markers.
  • Quality-controlled cells: donor screening, infectious disease testing, and laboratory quality testing before release.
  • Ultrasound-guided injections by specialists, using strict sterile technique.
  • Appropriate dosing: avoiding excessive volumes that increase post-injection pain.
  • Sedation when needed, with monitoring.
  • Observation and clear instructions, including warning signs and how to contact the team.

Preparing for a joint treatment

About seven days before treatment, pause anti-inflammatory painkillers such as ibuprofen, naproxen or aspirin for pain (low-dose aspirin prescribed for heart protection is reviewed by the doctor), as well as alcohol, tobacco and cannabis. Paracetamol and tramadol are generally allowed. Five days before, avoid dairy, fried or fatty foods and natural anti-inflammatories like omega 3, turmeric and ginger. Arrive fasting on the morning of the procedure and bring your imaging and medication list.

Recovery: protecting the treated joint

  • Day of treatment and next day: rest; avoid exercise.
  • First days: no ice or heat on the treated area on the day of treatment or the next day; from the third day, short applications are allowed as instructed.
  • Around day 10: walking up to 30 minutes on flat ground.
  • From week 2: start guided stretching and functional exercises without weight, ideally with a physical therapist.
  • Weeks 2 to 4 and beyond: gradual increases in resistance; avoid high impact and heavy load on the treated joint for about a month.
  • Alcohol: avoid for at least two weeks; continue avoiding anti-inflammatory supplements as instructed.

Returning to heavy load too early is one of the most common reasons for pain flares after treatment. If you work with a physical therapist, share your treatment date and these guidelines with them in advance, so your rehabilitation program can be adjusted to protect the treated joint while still keeping the surrounding muscles strong and active.

How joint treatment safety compares with alternatives

  • Corticosteroid injections: quick short-term relief but limited duration, and repeated injections may affect cartilage and tendons.
  • Hyaluronic acid injections: generally safe, but NICE does not recommend them for routine osteoarthritis care.
  • Joint replacement surgery: effective for advanced osteoarthritis but carries surgical risks such as infection, blood clots and a longer recovery.

Regenerative injections sit between conservative care and surgery: minimally invasive, with mostly temporary side effects, but with benefits that vary between patients.

Safety is not the same as effectiveness

A treatment can be safe without producing the improvement you hope for. Results vary with the severity of joint damage, body weight, alignment and rehabilitation. Patients with mild to moderate osteoarthritis or soft tissue injuries tend to have better chances than those with severe bone-on-bone disease.

Who may be a safe candidate

  • Joint pain with a confirmed diagnosis on recent imaging.
  • No active infection, uncontrolled bleeding risk or cancer within the past five years.
  • No prosthetic joint in the area to be treated.
  • Willingness to follow pre- and post-treatment instructions.
  • Realistic expectations about pain relief and function rather than a new joint.

Signs to report after treatment

Contact the team or seek urgent care for fever, increasing pain, redness or heat in the joint after the first few days, inability to bear weight, or numbness or weakness in the limb.

What our patients usually receive

Based on the treatment plans our team prepares for patients, a typical protocol at Stem Cell Mexico includes:

  • 20 to 40 million Wharton's jelly MSCs per treated area, applied by direct injection with ultrasound guidance, or fluoroscopy guidance for the spine.
  • Platelet-rich plasma (PRP) in many plans, applied together with the cells.
  • One night at our facilities with nursing and medical monitoring.
  • Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.
  • Your recent imaging: an MRI of the area no older than three months is requested; if yours is older, a new one can be scheduled in Tijuana on your arrival day.

Based on what patients tell us, many begin to notice improvement within a few days to a few weeks after the application, while others improve more gradually over the following months. Our team stays in contact after treatment to follow your progress and decide whether a second application or a PRP session could help.

Questions to ask during your evaluation

  • Which structures will be injected, and will ultrasound guidance be used?
  • How many cells will be used, and why?
  • What are my personal risk factors?
  • What should I do if pain or swelling increases?
  • What documentation will I receive about the cells?

Bottom line

Stem cell therapy for joint pain has a favorable safety record, with temporary local pain and swelling as the most common side effects and serious complications being rare. Safety depends on careful selection, ultrasound guidance, sterile technique, a documented cell product and a disciplined recovery. A medical evaluation can help determine whether this type of regenerative treatment is appropriate and safe for your joints, goals and medical history.

References

  1. Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
  2. NICE guideline NG226: Osteoarthritis in over 16s, diagnosis and management (opens in a new tab)
  3. International Society for Stem Cell Research (ISSCR): The ISSCR Guide to Stem Cell Treatments (opens in a new tab)
  4. U.S. Food and Drug Administration (FDA): Consumer alert on regenerative medicine products including stem cells and exosomes (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation